Massive Fund GMO Co’s $6 Billion Invested in Healthcare Stocks

Wall St. Watchdog reveals information regarding GMO Co’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 74 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $6.077 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, GMO Co reported holding 25,273,861 shares with a market value of $1,681,217,149. This comprised 5.77% of the total portfolio. On 09/30/2011, GMO Co reported holding 25,266,599 shares with a market value of $1,609,229,656. This comprised 5.62% of the total portfolio. The net change in shares for this position over the two quarters is -7,262. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, GMO Co reported holding 62,174,350 shares with a market value of $1,280,791,634. This comprised 4.4% of the total portfolio. On 09/30/2011, GMO Co reported holding 62,230,560 shares with a market value of $1,100,236,320. This comprised 3.84% of the total portfolio. The net change in shares for this position over the two quarters is 56,210. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, GMO Co reported holding 11,824,539 shares with a market value of $622,207,230. This comprised 2.14% of the total portfolio. On 09/30/2011, GMO Co reported holding 13,793,292 shares with a market value of $705,388,944. This comprised 2.46% of the total portfolio. The net change in shares for this position over the two quarters is 1,968,753. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, GMO Co reported holding 18,373,300 shares with a market value of $648,393,774. This comprised 2.23% of the total portfolio. On 09/30/2011, GMO Co reported holding 17,077,383 shares with a market value of $558,430,437. This comprised 1.95% of the total portfolio. The net change in shares for this position over the two quarters is -1,295,917. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, GMO Co reported holding 7,317,066 shares with a market value of $377,414,278. This comprised 1.3% of the total portfolio. On 09/30/2011, GMO Co reported holding 10,017,545 shares with a market value of $462,009,165. This comprised 1.61% of the total portfolio. The net change in shares for this position over the two quarters is 2,700,479. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, GMO Co reported holding 5,522,707 shares with a market value of $322,249,945. This comprised 1.11% of the total portfolio. On 09/30/2011, GMO Co reported holding 5,350,082 shares with a market value of $294,040,502. This comprised 1.03% of the total portfolio. The net change in shares for this position over the two quarters is -172,625. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, GMO Co reported holding 7,627,221 shares with a market value of $293,876,816. This comprised 1.01% of the total portfolio. On 09/30/2011, GMO Co reported holding 8,628,149 shares with a market value of $286,799,687. This comprised 1% of the total portfolio. The net change in shares for this position over the two quarters is 1,000,928. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, GMO Co reported holding 6,987,244 shares with a market value of $262,231,259. This comprised 0.9% of the total portfolio. On 09/30/2011, GMO Co reported holding 5,526,173 shares with a market value of $204,302,623. This comprised 0.71% of the total portfolio. The net change in shares for this position over the two quarters is -1,461,071. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Zimmer Holdings Inc. (NYSE:ZMH): On 06/30/2011, GMO Co reported holding 1,862,752 shares with a market value of $117,725,928. This comprised 0.4% of the total portfolio. On 09/30/2011, GMO Co reported holding 2,974,859 shares with a market value of $159,095,458. This comprised 0.56% of the total portfolio. The net change in shares for this position over the two quarters is 1,112,107. About Company: Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Zimmer markets its products in the United States and other countries around the world.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, GMO Co reported holding 1,256,629 shares with a market value of $98,984,662. This comprised 0.34% of the total portfolio. On 09/30/2011, GMO Co reported holding 1,416,948 shares with a market value of $92,498,364. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is 160,319. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.

(Note: Data regarding GMO Co’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>